Cerevance Inc

Cerevance, Inc. develops biopharmaceutical treatments for neurodegenerative, psychiatric, and CNS-controlled metabolic disorders. The Company advances novel therapies for conditions such as Parkinson's disease, Alzheimer's disease, ALS, and schizophrenia using proprietary drug discovery platforms. Cerevance Inc serves patients in Europe, the United Kingdom, and the United States.